Frontiers | Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials | Genetics
HDAC Inhibitors in the clinical trials. | Download Scientific Diagram
New HDAC inhibitors in clinical trials | Download Table
Characteristics of HDAC inhibitors in clinical trials. | Download Table
From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs | EMBO Molecular Medicine
Achieving clinical success with BET inhibitors as anti-cancer agents | British Journal of Cancer
The structures of five approved drugs (A) and HDAC inhibitors in... | Download Scientific Diagram
Pharmaco-transcriptomic correlation analysis reveals novel responsive signatures to HDAC inhibitors and identifies Dasatinib as a synergistic interactor in small-cell lung cancer - eBioMedicine
HDAC inhibitors currently under clinical investigation. Various HDAC... | Download Scientific Diagram
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials | Signal Transduction and Targeted Therapy
Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer | Anticancer Research
Current HDAC Inhibitor Clinical Trials for Patients With Melanoma or... | Download Table
HDAC inhibitors clinical status. The clinical trials information was... | Download Scientific Diagram
HDAC inhibitor-based therapies and haematological malignancy - Annals of Oncology
HDAC inhibitors studied in clinical trials in MM | Download Table
Histone deacetylase inhibitors: molecular mechanisms of action | Oncogene
HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases - ScienceDirect
Hydroxamic acid based HDAC inhibitors in clinical trials. | Download Table
FDA approved and selected ongoing clinical trials involving HDAC... | Download Scientific Diagram
Histone deacetylase (HDAC) inhibitors used in clinical trials arranged... | Download Scientific Diagram
Histone Deacetylase Inhibitors in Malignant Pleural Mesothelioma: Preclinical Rationale and Clinical Trials - Journal of Thoracic Oncology
Frontiers | Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease | Cell and Developmental Biology
